Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Somatostatin may help protect hair follicles from immune attacks.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

CD99 is highly present in certain skin cells and could help treat skin conditions.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

CD2 might be a new treatment target for patchy alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

Eating shiitake mushrooms caused a man to develop a rash similar to a skin condition known as AGEP.